创模生物科技（北京）有限公司
创模生物科技（北京）有限公司

Cn / En

InnoModels

InnoModels

Provide top-quality preclinical services to pharmaceutical enterprises and translational research institutions
InnoModels

InnoModels

Have an experienced and high-performing management and research team
InnoModels

InnoModels

Focus on the development and application of oncology and Immun-oncology models
InnoModels

InnoModels

Combine innovative preclinical technology and unrivaled expertise to enable more efficient drug discovery and development
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司
创模生物科技（北京）有限公司

R&D Service Platform

服务特色

Humanized mice for l/O

iHuPBMC-T ， iHuPBMC-NK，iHuPBMC-B， iHuPBMC-Donor screening and QC, iHuPBMC-OncVax medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models.

创模生物科技（北京）有限公司

Oncology in vivo

CDX models，iHuPDX models，

 Orthotopic models，

Orthotopic mouse brain models...

创模生物科技（北京）有限公司

in vitro cytotoxicity test

Patient-derived tumor cell screening,  3D orgnoid, IC50, Immunue cells mediated tumor killing assays immunotherapy to provide close to the clinical trials of a new generation of animal models.

创模生物科技（北京）有限公司

Syngeneic models for l/O

Syngeneic models,

NK function assay in SCID mice, Genetically engineered mouse models

创模生物科技（北京）有限公司

Cancer vaccine evaluation

Syngeneic-OncVax for cancer vaccine, MHC humanized mouse

创模生物科技（北京）有限公司

Cell therapy

Car-T,Car-NK,

 Car-T in MHC/KO mice, 

Host vs graft (HVG)   

创模生物科技（北京）有限公司

in vitro immune assay

ELISpot,

ELISA,

FACS, qPCR 

创模生物科技（北京）有限公司

Non-GLP tox

GVHD experimental platform，

Immunogenicity Testing

创模生物科技（北京）有限公司

PDX model

Lymphoma (LY),Chronic myeloproliferitve neoplasm (CMP), Myelodisplasic syndrome (MDS)  

创模生物科技（北京）有限公司

CDX model

Eosinophilia (EOS), Leukemia (LK), Myeloma (MYMA), Mastocytosis (MAS), Musculoskeletal and vascular systems (MSKV) 

创模生物科技（北京）有限公司

Homologous model

Nervous system (NS),Urinary system (US),Endocrine System (ES), 

Female reproductory system (FRS)... 

创模生物科技（北京）有限公司

Database 

【Database 1】

【Database 2】

InnoModels News

创模生物科技（北京）有限公司

InnoModels has a stable immune system humanized mouse model platform (HIS) and a human tumor allotransplantation platform (PDX) in China.

imgboxbg

News and Events

InnoModels always adhere to the quality of development, quality of survival principle, to promote the company to the development of collectivized economy

Immunoco-culture killing model from InnoModels Biotechnology
Company News
Immunoco-culture killing model from InnoModels Biotechnology
14 09
News and Events
Immunoco-culture killing model from InnoModels Biotechnology
With the continuous development of oncology and immunology, finding more effective treatments has become a common goal for scientists and doctors. In this context, the PBMC-tumor cell co-culture killing platform, an immunoculture killing model launched by InnoModels Biotechnology (Beijing) Co., Ltd. has become an important breakthrough in immunocidal research in vitro. This innovative model not only provides researchers with an experimental platform that is closer to the physiological situation in vivo, but also brings new possibilities for the development and evaluation of immunotherapeutic drugs.
13 09
News and Events
InnoModels Biotechnology qPCR Platform
In today's era of rapid biotechnology development, the research and development of oncology drugs are facing unprecedented challenges and opportunities. In order to more accurately assess drug effects, optimize drug structure and promote early drug release, scientists are constantly seeking more efficient and precise detection methods. InnoModels Biotechnology (Beijing) Co., Ltd. provides strong technical support for oncology drug research and development with its advanced qPCR (real-time quantitative polymerase chain reaction) platform.
12 09
News and Events
Advantages of the InnoModels Biotechnology Inflammatory Bowel Disease (IBD) Model
Inflammatory Bowel Disease (IBD) is a group of complex, recurrent inflammatory diseases of the intestines, mainly including Crohn's Disease (CD) and Ulcerative Colitis (UC). As the incidence of IBD rises, the study of its pathogenesis and therapeutics becomes particularly important. Modeling organisms, especially mouse models, play a key role in this field. In this paper, we will introduce the advantages of InnoModels Biotechnology IBD models in detail.
11 09
News and Events
Features of the Luminex platform from InnoModels Biotechnology
InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.

About InnoModels

创模生物科技（北京）有限公司

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models. Gen die creature has domestic stability of the humanized mice immune system model (ihs) platform, and anthropogenic tumor allografts platform (symbol), focusing on tumor and tumor immune pharmacodynamics CRO services, translational medicine research service, individualized medicine, service transformation of new drug research and development enterprise, medical researchers, cancer patients, is dedicated to the research and development of tumor and tumor immunotherapy to provide close to the clinical trials of a new generation of animal models.

Home
Services
Humanized mice for l/O Oncology in vivo In vitro cytotoxicity test Syngeneic models for l/O Cancer vaccine evaluation Cell therapy In vitro immune assay Non-GLP tox Non-tumor model and drug efficacy evaluation platform
Model
PDX model CDX model Syngenic model
Database
CDX model in vivo database Homology model in vivo database
About us
Company Profile Contact us Recruiting Development course Honorary certificate Team Collaborative research achievements
News
Company news Industry news

InnoModels Biotechnology (Beijing) Co., Ltd

TEL：15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

创模生物科技（北京）有限公司